Literature DB >> 10622746

Somatostatin receptor subtype 1 modulates basal inhibition of growth hormone release in somatotrophs.

H J Kreienkamp1, E Akgün, H Baumeister, W Meyerhof, D Richter.   

Abstract

Somatostatin (SST) inhibits the secretion of many peptide hormones including growth hormone (GH). The various functions of SST are mediated through at least five different receptor subtypes (SSTR1-5), their precise physiological roles have not been solved yet. Here we report on studies concerning the functional role of SSTR1 in the modulation of GH release from somatotrophs. Primary cell cultures from pituitaries of wild-type SSTR1 mice exposed to the SSTR1 selective somatostatin analog CH-275 show reduction of basal levels of GH secretion whereas somatotrophs isolated from SSTR1 null mutant mice did not respond to the agonist-mediated effect. This suggests that SSTR1 is involved in modulating basal GH levels in primary pituitary cell cultures and, together with SSTR2, may control the secretion of GH in the body.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10622746     DOI: 10.1016/s0014-5793(99)01582-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

1.  Somatostatin coupling to adenylyl cyclase activity in the mouse retina.

Authors:  Barbara Pavan; Sara Fiorini; Massimo Dal Monte; Laura Lunghi; Carla Biondi; Paola Bagnoli; Davide Cervia
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-08-12       Impact factor: 3.000

2.  Protective role of somatostatin receptor 2 against retinal degeneration in response to hypoxia.

Authors:  Massimo Dal Monte; Valentina Latina; Elena Cupisti; Paola Bagnoli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-02-07       Impact factor: 3.000

3.  Effect of gsp oncogene on somatostatin receptor subtype 1 and 2 mRNA levels in GHRH-responsive GH3 cells.

Authors:  Eunhee Kim; Sookjin Sohn; Mina Lee; Cheolyoung Park; Jeechang Jung; Seungjoon Park
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

4.  Hippocampal SSTR4 somatostatin receptors control the selection of memory strategies.

Authors:  François Gastambide; Cécile Viollet; Gabriel Lepousez; Jacques Epelbaum; Jean-Louis Guillou
Journal:  Psychopharmacology (Berl)       Date:  2008-06-03       Impact factor: 4.530

Review 5.  International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.

Authors:  Thomas Günther; Giovanni Tulipano; Pascal Dournaud; Corinne Bousquet; Zsolt Csaba; Hans-Jürgen Kreienkamp; Amelie Lupp; Márta Korbonits; Justo P Castaño; Hans-Jürgen Wester; Michael Culler; Shlomo Melmed; Stefan Schulz
Journal:  Pharmacol Rev       Date:  2018-10       Impact factor: 25.468

6.  Somatostatin is required for masculinization of growth hormone-regulated hepatic gene expression but not of somatic growth.

Authors:  M J Low; V Otero-Corchon; A F Parlow; J L Ramirez; U Kumar; Y C Patel; M Rubinstein
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

Review 7.  Somatostatin and somatostatin receptor physiology.

Authors:  Philip Barnett
Journal:  Endocrine       Date:  2003-04       Impact factor: 3.633

8.  Novel, potent, and radio-iodinatable somatostatin receptor 1 (sst1) selective analogues.

Authors:  Judit Erchegyi; Renzo Cescato; Christy Rani R Grace; Beatrice Waser; Véronique Piccand; Daniel Hoyer; Roland Riek; Jean E Rivier; Jean Claude Reubi
Journal:  J Med Chem       Date:  2009-05-14       Impact factor: 7.446

9.  Adenylyl cyclase/cAMP system involvement in the antiangiogenic effect of somatostatin in the retina. Results from transgenic mice.

Authors:  Chiara Ristori; Maria Enrica Ferretti; Barbara Pavan; Franco Cervellati; Giovanni Casini; Elisabetta Catalani; Massimo Dal Monte; Carla Biondi
Journal:  Neurochem Res       Date:  2008-02-13       Impact factor: 3.996

10.  Characterisation of [125I]-Tyr0DTrp8-somatostatin binding in sst1- to sst4- and SRIF-gene-invalidated mouse brain.

Authors:  Catherine Videau; Ute Hochgeschwender; Hans Jürgen Kreienkamp; Miles B Brennan; Cécile Viollet; Dietmar Richter; Jacques Epelbaum
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-05-21       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.